Outcomes of patients with peripheral T-cell lymphoma in first complete remission: data from three tertiary Asian cancer centers.
作者信息
Tang Tiffany, Khoo Lay Poh, Lim Cindy, Ham Jun Soo, Kim Seok Jin, Hong Huangming, Phipps Colin, Lee Yuh Shan, Tao Miriam, Quek Richard, Farid Mohamad, Lin Tongyu, Kim Won Seog, Lim Soon Thye
机构信息
Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.
Division of Clinical Trials and Epidemiological Sciences, National Cancer Centre Singapore, Singapore, Singapore.
出版信息
Blood Cancer J. 2017 Dec 15;7(12):653. doi: 10.1038/s41408-017-0030-y.
Abstract
摘要
相似文献
1
Outcomes of patients with peripheral T-cell lymphoma in first complete remission: data from three tertiary Asian cancer centers.外周T细胞淋巴瘤患者首次完全缓解后的结局：来自三个亚洲三级癌症中心的数据。
Blood Cancer J. 2017 Dec 15;7(12):653. doi: 10.1038/s41408-017-0030-y.
2
Therapeutic effects and influencing factors in sixty-eight cases of peripheral T-cell lymphoma unspecified.68例非特指外周T细胞淋巴瘤的治疗效果及影响因素
Tumori. 2014 Jan-Feb;100(1):21-5. doi: 10.1700/1430.15810.
3
Autologous stem cell transplantation as consolidation therapy for patients with peripheral T cell lymphoma in first remission: long-term outcome and risk factors analysis.自体造血干细胞移植作为一线缓解的外周 T 细胞淋巴瘤患者的巩固治疗：长期结果和风险因素分析。
Ann Hematol. 2013 Jul;92(7):925-33. doi: 10.1007/s00277-013-1716-2. Epub 2013 Mar 8.
4
Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01. upfront 自体干细胞移植在外周 T 细胞淋巴瘤中的应用：NLG-T-01
J Clin Oncol. 2012 Sep 1;30(25):3093-9. doi: 10.1200/JCO.2011.40.2719. Epub 2012 Jul 30.
5
Comparison of long-term clinical outcomes of CHOP chemotherapy between Japanese patients with nodal peripheral T-cell lymphomas and those with diffuse large B-cell lymphoma in the study group of the Tohoku Hematology Forum.在东北血液学论坛研究组中，日本结节性外周T细胞淋巴瘤患者与弥漫性大B细胞淋巴瘤患者CHOP化疗的长期临床结果比较。
J Clin Exp Hematop. 2011;51(1):29-35. doi: 10.3960/jslrt.51.29.
6
Clinical and prognostic differences between ALK-negative anaplastic large cell lymphoma and peripheral T cell lymphoma, not otherwise specified: a single institution experience.ALK阴性间变性大细胞淋巴瘤与外周T细胞淋巴瘤（非特指型）之间的临床及预后差异：单中心经验
Ann Hematol. 2016 Aug;95(8):1271-80. doi: 10.1007/s00277-016-2696-9. Epub 2016 May 21.
7
The impact of stem cell transplantation on the natural course of peripheral T-cell lymphoma: a real-world experience.干细胞移植对周围 T 细胞淋巴瘤自然病程的影响：真实世界经验。
Ann Hematol. 2018 Jul;97(7):1241-1250. doi: 10.1007/s00277-018-3288-7. Epub 2018 Mar 16.
8
Analysis of prognostic factors for survival in 75 Chinese patients with peripheral T-cell lymphoma.75例中国外周T细胞淋巴瘤患者生存预后因素分析
Leuk Lymphoma. 2014 Apr;55(4):959-61. doi: 10.3109/10428194.2013.813508. Epub 2013 Aug 28.
9
Treatment response and overall outcome of patients with relapsed and refractory peripheral T-cell lymphoma compared to diffuse large B-cell lymphoma.与弥漫性大 B 细胞淋巴瘤相比，复发/难治性外周 T 细胞淋巴瘤患者的治疗反应和总体结局。
Leuk Lymphoma. 2013 Mar;54(3):507-13. doi: 10.3109/10428194.2012.719615. Epub 2012 Sep 8.
10
Phase I dose escalation study of the anti-CD2 monoclonal antibody, siplizumab, with DA-EPOCH-R in aggressive peripheral T-cell lymphomas.抗CD2单克隆抗体西普利单抗联合DA-EPOCH-R方案用于侵袭性外周T细胞淋巴瘤的I期剂量递增研究。
Leuk Lymphoma. 2018 Jun;59(6):1466-1469. doi: 10.1080/10428194.2017.1387908. Epub 2017 Oct 16.
引用本文的文献
1
Role of upfront autologous transplant for peripheral T-cell lymphoma patients achieving a complete remission with first-line therapy: a systematic review and meta-analysis.一线治疗后达到完全缓解的外周 T 细胞淋巴瘤患者行 upfront 自体移植的作用：系统评价和荟萃分析。
Bone Marrow Transplant. 2024 Jun;59(6):838-848. doi: 10.1038/s41409-024-02254-x. Epub 2024 Mar 5.
2
Diagnostic significance of dysregulated miRNAs in T-cell malignancies and their metabolic roles.失调的微小RNA在T细胞恶性肿瘤中的诊断意义及其代谢作用。
Front Oncol. 2023 Aug 10;13:1230273. doi: 10.3389/fonc.2023.1230273. eCollection 2023.
3
Current Treatment Patterns and the Role of Upfront Autologous Stem Cell Transplantation in Patients with Peripheral T-Cell Lymphoma: A Korean Nationwide, Multicenter Prospective Registry Study (CISL 1404).目前外周 T 细胞淋巴瘤患者的治疗模式和 upfront 自体干细胞移植的作用：一项韩国全国性、多中心前瞻性注册研究（CISL 1404）。
Cancer Res Treat. 2023 Apr;55(2):684-692. doi: 10.4143/crt.2022.1434. Epub 2023 Jan 2.
4
Impact of Epstein-Barr Virus on Peripheral T-Cell Lymphoma Not Otherwise Specified and Angioimmunoblastic T-Cell Lymphoma.爱泼斯坦-巴尔病毒对未另行指定的外周T细胞淋巴瘤和血管免疫母细胞性T细胞淋巴瘤的影响。
Front Oncol. 2022 Jan 11;11:797028. doi: 10.3389/fonc.2021.797028. eCollection 2021.
5
Comprehensive analysis of peripheral T-cell and natural killer/T-cell lymphoma in Asian patients: A multinational, multicenter, prospective registry study in Asia.亚洲患者外周T细胞和自然杀伤/T细胞淋巴瘤的综合分析：一项在亚洲开展的多国家、多中心前瞻性注册研究。
Lancet Reg Health West Pac. 2021 Mar 22;10:100126. doi: 10.1016/j.lanwpc.2021.100126. eCollection 2021 May.
6
Invited Review: Will Consolidation with ASCT Be a Thing of the Past for MCL and PTCL?特邀评论：ASCT 巩固治疗是否将成为 MCL 和 PTCL 的过去式？
Curr Hematol Malig Rep. 2021 Feb;16(1):82-88. doi: 10.1007/s11899-021-00609-5. Epub 2021 Mar 1.
本文引用的文献
1
Outcome of peripheral T-cell lymphoma in first complete remission: a Danish-Swedish population-based study.初治完全缓解的外周T细胞淋巴瘤的转归：一项基于丹麦和瑞典人群的研究
Leuk Lymphoma. 2017 Dec;58(12):2815-2823. doi: 10.1080/10428194.2017.1300888. Epub 2017 Mar 20.
2
Autologous stem cell transplantation in first complete remission may not extend progression-free survival in patients with peripheral T cell lymphomas.自体干细胞移植在首次完全缓解后可能不会延长外周 T 细胞淋巴瘤患者的无进展生存期。
Am J Hematol. 2016 Jul;91(7):672-6. doi: 10.1002/ajh.24372. Epub 2016 Apr 24.
3
The 2016 revision of the World Health Organization classification of lymphoid neoplasms.《世界卫生组织淋巴组织肿瘤分类（2016年修订版）》
Blood. 2016 May 19;127(20):2375-90. doi: 10.1182/blood-2016-01-643569. Epub 2016 Mar 15.
4
Peripheral T-cell lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.外周T细胞淋巴瘤：ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2015 Sep;26 Suppl 5:v108-15. doi: 10.1093/annonc/mdv201.
5
Peripheral T-cell lymphomas in a large US multicenter cohort: prognostication in the modern era including impact of frontline therapy.美国一个大型多中心队列中的外周T细胞淋巴瘤：现代预后评估，包括一线治疗的影响。
Ann Oncol. 2014 Nov;25(11):2211-2217. doi: 10.1093/annonc/mdu443. Epub 2014 Sep 5.
6
Real-world data on prognostic factors and treatment in peripheral T-cell lymphomas: a study from the Swedish Lymphoma Registry.真实世界外周 T 细胞淋巴瘤的预后因素和治疗数据：来自瑞典淋巴瘤登记处的一项研究。
Blood. 2014 Sep 4;124(10):1570-7. doi: 10.1182/blood-2014-04-573089. Epub 2014 Jul 8.
7
How I treat NK/T-cell lymphomas.我如何治疗 NK/T 细胞淋巴瘤。
Blood. 2013 Jun 20;121(25):4997-5005. doi: 10.1182/blood-2013-01-453233. Epub 2013 May 7.
8
Type II EATL (epitheliotropic intestinal T-cell lymphoma): a neoplasm of intra-epithelial T-cells with predominant CD8αα phenotype.II 型 EATL（上皮嗜肠道 T 细胞淋巴瘤）：一种上皮内 T 细胞肿瘤，以 CD8αα 表型为主。
Leukemia. 2013 Aug;27(8):1688-96. doi: 10.1038/leu.2013.41. Epub 2013 Feb 12.
9
Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01. upfront 自体干细胞移植在外周 T 细胞淋巴瘤中的应用：NLG-T-01
J Clin Oncol. 2012 Sep 1;30(25):3093-9. doi: 10.1200/JCO.2011.40.2719. Epub 2012 Jul 30.
10
Should eligible patients with T-cell lymphoma receive high-dose therapy and autologous stem cell transplant in the upfront setting?适合的 T 细胞淋巴瘤患者是否应在初始治疗中接受大剂量化疗和自体造血干细胞移植？
Curr Oncol Rep. 2010 Nov;12(6):374-82. doi: 10.1007/s11912-010-0125-0.
Zotero 插件